Ernesto Fedele Selected Research

Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)

4/2022	MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
9/2019	Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression.
2/2015	Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ernesto Fedele Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 09/2023 - 02/2013
8	Parkinson Disease (Parkinson's Disease) 04/2022 - 03/2005
3	Vomiting 01/2023 - 11/2016
3	Disease Progression 01/2023 - 06/2009
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2022 - 02/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2023 - 04/2022
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 10/2010
2	Dyskinesias (Dyskinesia) 05/2017 - 06/2009
1	Spinal Cord Injuries (Spinal Cord Injury) 05/2024
1	Inflammation (Inflammations) 01/2023
1	Huntington Disease (Huntington's Disease) 04/2022
1	Multiple Sclerosis 04/2022
1	Mental Disorders (Mental Disorder) 10/2019
1	Cognitive Dysfunction 01/2017
1	Intellectual Disability (Idiocy) 01/2017
1	Parkinsonian Disorders (Parkinsonism) 09/2009
1	Nervous System Diseases (Neurological Disorders) 08/2008

Drug/Important Bio-Agent (IBA)

5	Amyloid (Amyloid Fibrils)IBA 09/2023 - 12/2015
4	Peptides (Polypeptides)IBA 09/2023 - 12/2015
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 05/2024 - 01/2023
3	EnzymesIBA 06/2023 - 10/2015
3	Glutamic Acid (Glutamate)FDA Link 09/2019 - 10/2010
2	Protein Isoforms (Isoforms)IBA 12/2017 - 10/2015
2	Dopamine (Intropin)FDA LinkGeneric 05/2017 - 06/2009
2	Amyloid beta-PeptidesIBA 01/2017 - 02/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	RoflumilastIBA 01/2023
1	Phosphodiesterase 4 InhibitorsIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2019
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 09/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Homovanillic AcidIBA 05/2017
1	GDP dissociation inhibitor 1IBA 01/2017
1	GEBR-7bIBA 11/2016
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2016
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2015
1	gamma-Aminobutyric Acid (GABA)IBA 02/2015
1	amphiphysinIBA 02/2015
1	Leucine (L-Leucine)FDA Link 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	D-Aspartic Acid (D Aspartate)IBA 10/2010
1	RotenoneIBA 08/2008
1	PesticidesIBA 08/2008

Therapy/Procedure

4	Therapeutics 09/2023 - 01/2021
4	Deep Brain Stimulation 01/2011 - 03/2005